Conference Report Location:HomeCPC MeetingConference ReportDetails

Publication and interpretation meeting of "guidelines for diagnosis and treatment of psoriasis in China"

Source:China psoriasis Congress    Date:2018/10/26    Browse:1769 second

        On the afternoon of October 26, 2018, the release and interpretation meeting of Chinese psoriasis diagnosis and treatment guidelines was successfully held in Hefei Buckingham Hotel. The guidelines were jointly compiled by 34 well-known experts from dermatology and Venereology branch of Chinese Medical Association, dermatology branch of Chinese Traditional Medicine Association and dermatology branch of Chinese Integrative Medicine Association, aiming to develop a practical, operable and effective method The guidelines for the diagnosis and treatment of psoriasis with Chinese characteristics standardize the diagnosis and treatment of psoriasis by dermatologists, and lay a good start for the formulation of various guidelines for skin diseases in China.

        The press conference was presided over by Professor Zheng Min, member of the international psoriasis Association (IPC) and deputy leader of the psoriasis group (Special Committee) of the dermatology and Venereology branch of the Chinese Medical Association.

Figure 1

        First of all, Professor Zhang Xuejun, member of the international psoriasis Association (IPC), China coordinator of the international psoriasis surveillance program (GPA), head of the psoriasis group (Special Committee) of the dermatology and Venereology branch of the Chinese Medical Association, and chairman of the guidelines for the diagnosis and treatment of psoriasis in China, Professor Zhang Xuejun released the guidelines, introduced the compilation and revision process of the guidelines, and pointed out that The current guidelines for psoriasis diagnosis and treatment in China are lack of uniform standards, consensus and guidelines formulated by different industries are divergent, lack of authority and guidance, and professional doctors are at a loss, which greatly reduces the industry guidance role of the guidelines and consensus. This edition of guidelines is compiled and improved on the basis of previous Chinese psoriasis treatment guidelines, which integrates China Characteristics of traditional Chinese medicine. Chinese version and English China one belt, one road edition, will be published in the Chinese version of the guide, which will reflect the characteristics of Chinese medicine in China. Zhang Xuejun will also exchange and promote the national strategy of "one belt and one road" in this edition.

Figure 2

        Professor Zhang Xibao, deputy leader of psoriasis group (Special Committee) of Dermatology and Venereology branch of Chinese Medical Association and Secretary General of China psoriasis diagnosis and treatment guidelines, made a detailed interpretation of this edition of guidelines, introduced the current situation of psoriasis diagnosis and treatment, the scope of application of this edition of guidelines, the etiology and pathogenesis of psoriasis, clinical manifestations, diagnosis, classification and staging, treatment, management and prevention, etc., to guide me The diagnosis and treatment of psoriasis in China was standardized.

Figure 3

        In addition to dermatologists from all over the country, there were also patient representatives from the psoriatic patients' Union. It is hoped that the publication of this guideline can further standardize the diagnosis and treatment of psoriasis by dermatologists, and promote the integration of China's psoriasis diagnosis and treatment with the world.

Figure 4

Fig5


China Psoriasis Network CPC2020

Xu Xiangmei (Conference consultation)
Mobile:15005604686
Email:1225856963@qq.com
Zhu Xiaofeng (Registration consulting)
Mobile:15156991066
Email:307676249@qq.com

Copyright: China Psoriasis Network Wanicp Bei 11019793 皖公网安备 34019202000792号